MedPath
HSA Approval

RESOLVE SOLUTION 2% w/w

SIN10836P

RESOLVE SOLUTION 2% w/w

RESOLVE SOLUTION 2% w/w

March 24, 1999

EGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.

EGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantEGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.
Licence HolderEGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SOLUTION

TOPICAL

Medical Information

D01AC02

miconazole

Manufacturer Information

EGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.

EGO PHARMACEUTICALS PTY LTD

Active Ingredients

MICONAZOLE

2% w/w

Miconazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RESOLVE SOLUTION 2% w/w - HSA Approval | MedPath